Model-reported gaps from the latest successful review. Decision cutoff: Nov 7, 2026, 8:17 PM EST · Review completed: Nov 7, 2026, 8:20 PM EST. These explanations have not been independently verified.

• Which identified projects have documented delays or cancelled accelerator or memory orders affecting revenue before October 27, 2027?

  Why unresolved: The newly reviewed AP report describes political and market concerns but supplies no holding-specific order or revenue bridge.
  Decision impact: Deployment risk limits additions to NVDA and MU; political sentiment alone does not establish a reason to liquidate them.
  Next research step: Check primary permitting decisions, customer construction updates and supplier delivery or backlog amendments for identifiable revenue exposure.

• What will NVIDIA's forthcoming quarterly disclosures establish about guidance, collections and customer financing exposure?

  Why unresolved: The report is scheduled for November 17 and is unpublished at the cutoff. Its future outcome cannot be verified through additional browsing today.
  Decision impact: Retain the earnings-supported core while withholding additions; reassess if funding dependence or cash conversion deteriorates.
  Next research step: Review the November 17 release, CFO commentary and subsequent filing for receivables, operating cash flow, investments and financing commitments.

• What cancellation, default and repricing remedies govern Micron's customer agreements, and what disclosed sensitivities quantify lower-price earnings risk?

  Why unresolved: Prepared remarks establish meaningful contractual protections but do not provide complete agreement terms or a normalized profitability stress test.
  Decision impact: The evidence strengthens retention, but does not justify extrapolating exceptional margins or increasing concentration.
  Next research step: Examine subsequent filings for agreement terms, deposit accounting, contract liabilities, receivable quality and pricing changes.

• What is Lilly's product-level recurring-revenue and net-pricing bridge after removing Q3 milestone and rebate-estimate benefits?

  Why unresolved: The release quantifies aggregate benefits and volume/pricing movements, but these do not fully isolate recurring product economics.
  Decision impact: Maintain the smaller position; do not capitalize temporary benefits or assume access expansion offsets future price pressure.
  Next research step: Compare subsequent product sales, prescription trends and realized pricing with the disclosed Q3 adjustments.

• What are comparable recurring-earnings and free-cash-flow valuations for AMD, Microsoft and Airbnb using November 6, 2026 closing references?

  Why unresolved: AMD's historical screen is available, but the retrieved Microsoft official price table ends November 5. The attempted Airbnb shareholder-letter PDF was inaccessible, although its newsroom summary opened.
  Decision impact: Do not rotate into an alternative based only on growth headlines. Historical annualization screens are not equivalent to forward recurring valuations.
  Next research step: Obtain Airbnb's filed quarterly statements, normalize cash generation and dilution across candidates, and align research prices to one completed session.